UTMD (Utah Medical Products Inc) Stock Analysis - AI Report
Utah Medical Products Inc (UTMD) is a publicly traded Healthcare sector company. As of May 21, 2026, UTMD trades at $64.17 with a market cap of $203.78M and a P/E ratio of 19.03. UTMD moved +0.00% today. Year to date, UTMD is +11.41%; over the trailing twelve months it is +18.35%. Its 52-week range spans $51.26 to $71.81. Rallies surfaces UTMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on UTMD?
Rallies AI research for UTMD combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
RICHINS PAUL O sold 700 (~$65.43K) on May 18, 2023.
RICHINS PAUL O sold 449 (~$40.77K) on Nov 18, 2022.
RICHINS PAUL O sold 161 (~$14.49K) on Nov 17, 2022.
UTMD Analyst Consensus
UTMD analyst coverage data. Average price target: $0.00.
Common questions about UTMD
What is the AI research view on UTMD?
Rallies AI research for UTMD combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for UTMD?
Rallies AI research for UTMD combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is UTMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for UTMD. It does not provide personalized investment advice.
